Touchlight Genetics Ltd is a biotechnology company operating in the field of DNA therapies and DNA technology. The Company develops an enzymatic means of DNA amplification that addresses all major limitations of plasmid DNA. Touchlight's in vitro dual enzyme process can amplify any circular template to commercial scale and quality. The Company's doggybone or dbDNA is a linear covalently closed, minimal DNA construct that contains no bacterial sequences. Touchlight's ambition is for dbDNA to underpin the development and commercialisation of the next generation of DNA products.